高级检索
当前位置: 首页 > 详情页

THE INVOLVEMENT AND MECHANISM OF FEBUXOSTAT IN NON-ALCOHOLIC FATTY LIVER DISEASE CELLS

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Cent S Univ, Xiangya Hosp, Dept Endocrinol, Changsha, Hunan, Peoples R China [2]First Hosp Harbin, Dept Endocrinol, Harbin, Heilongjiang, Peoples R China [3]Harbin Med Univ, Canc Hosp, Dept Crit Care Med, Harbin, Heilongjiang, Peoples R China [4]Capital Med Univ, Beijing Friendship Hosp, Dept Anesthesiol, Beijing, Peoples R China
出处:
ISSN:

关键词: nonalcoholic fatty liver disease febuxostat inflammasomes insulin resistance therapeutic options

摘要:
It has been proved that hyperuricemia is associated with non-alcoholic fatty liver disease (NAFLD). The xanthine oxidase (XO) inhibitor, febuxostat, decreases free fatty acids-induced fat accumulation in HFDT-fed mice. Here, it is shown that febuxostat attenuates fat accumulation and reactive oxygen species (ROS) in HepG2 cells. It was further found that the underlying mechanism is related to the reduction in expression of NLRP3/caspase-1/IL-18/IL-1beta and improved insulin resistance (IR). This finding highlights the possible molecular pathways involving NLRP3 activation for management of ROS and insulin IR. In conclusion, febuxostat may be a promising potential treatment for patients with NAFLD.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 内分泌学与代谢 4 区 免疫学 4 区 医学:研究与实验 4 区 生理学
最新[2025]版:
JCR分区:
出版当年[2016]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHYSIOLOGY Q4 IMMUNOLOGY Q4 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q4 ENDOCRINOLOGY & METABOLISM Q4 IMMUNOLOGY Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHYSIOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2016版] 出版当年五年平均[2012-2016] 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者单位: [1]Cent S Univ, Xiangya Hosp, Dept Endocrinol, Changsha, Hunan, Peoples R China
通讯作者:
通讯机构: [1]Cent S Univ, Xiangya Hosp, Dept Endocrinol, Changsha, Hunan, Peoples R China [*1]Cent S Univ, Xiangya Hosp, Xiangya Rd 87, Changsha 410008, Hunan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)